Surmounting Recalcitrant Airway Inflammatory Disorders With a Multi-Targeting Therapeutic Strategy by Tannic Acid-Modified CuInP<sub>2</sub>S<sub>6</sub> Nanosheets.

Exploration (Beijing) · 2026 · PMC13094517 · PMID 42016762

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

barely significantno p-value reported

In addition, barely significant differences were observed in levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatinine (CREA), urea (URE), and creatine kinase (CK) (Figure S38 ), indicating the hepatic and renal functions were not injured by nanosheets.

also in 875 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Surmounting Recalcitrant Airway Inflammatory Disorders With a Multi-Targeting Therapeutic Strategy by Tannic Acid-Modified CuInP&lt;sub&gt;2&lt;/sub&gt;S&lt;sub&gt;6&lt;/sub&gt; Nanosheets.

The sentences

Surmounting Recalcitrant Airway Inflammatory Disorders With a Multi-Targeting Therapeutic Strategy by Tannic Acid-Modified CuInP<sub>2</sub>S<sub>6</sub> Nanosheets.